Adrenoleucodystrophy mimicking multiple sclerosis;Adrenoleukodystrophie kann multiple sklerose imitieren

Nervenarzt

Volumn 72, Issue 10, 2001, Pages 794-797

  Krenn, M ^a   Bonelli, R M ^a   Niederwieser, G ^a   Reisecker, F ^a   Koltringer P ^a  

^a Krankenhaus BHB Eggenberg   (Austria)

Author keywords

Adrenoleucodystrophy; Multiple sclerosis; Very long chain fatty acids

Indexed keywords

VERY LONG CHAIN FATTY ACID;

ADRENOLEUKODYSTROPHY; ADULT; ARTICLE; BRAIN SCINTISCANNING; CASE REPORT; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; MULTIPLE SCLEROSIS; PATHOGENESIS; X CHROMOSOME LINKED DISORDER;

ADRENOLEUKODYSTROPHY; ADULT; DIAGNOSIS, DIFFERENTIAL; EVOKED POTENTIALS; FATTY ACIDS; FEMALE; FIBROBLASTS; HETEROZYGOTE; HUMANS; IMMUNOGLOBULINS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; PHENOTYPE;

EID: 0034792760     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001150170037     Document Type: Article

References (30)

1. On the front of X-liked adrenoleukodystrophy
2. Adrenoleukodystrophy mimicking multiple sclerosis
3. The neurobiology of x-linked adrenoleukodystrophy, a demyelinating peroxisomal disorder
4. Clinical and genetic aspects of X-linked adrenoleukodystrophy
5. Identification of the inflammatory cells in the central nervous system of patients with adrenoleukodystrophy
6. MRT der adrenoleukodystrophie
7. Interaction of very long chain fatty acid with model membranes and serum albumin: Implications for the pathogenesis of adrenoleukodystrophy
8. Carrier identification of X-linked adrenoleukodystrophy by measurement of very long chain fatty acids and lignoceric acid oxidation
9. Progression of X-linked adrenoleukodystrophy under interferon β therapy
10. Identification of mutations in the ALD-gene of 20 families with adrenoleukodystrophy/adrenomyeloneuropathy
11. X-linked adrenoleukodystrophy presenting as neurologically pure familial spastic paraparesis
12. Human leukocyte antigens and cytokine expression in cerebral inflammatory demyelinative lesions of X-linked adrenoleukodystrophy and multiple sclerosis
13. Adrenoleukodystrophy: Phenotype,genetics,pathogenesis and therapy
14. Adrenoleukodystrophy update: Genetics and effect of Lorenzo's oil. Therapy in asymptomatic patients
15. Measurements of saturated very long chain fatty acids in plasma
16. Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy
17. Adrenoleukodystrophy: Phenotypic variability: Implications for therapy
18. The identification of female carriers for adrenoleukodystrophy
19. Adrenoleukodystrophy: Molecular genetics, pathology and Lorenzo's oil
20. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
21. Adrenoleukodystrophy: A clinical variant presenting as olivopontocerebellar atrophy
22. Central nervous system white matter diseases other than multiple sclerosis
23. Adrenoleukodystrophy
24. The inflammatory myelinopathy of adrenoleukodystrophy: Cells, effector molecules and pathogenetic implications
25. Peroxisomal disorders: Genotype, phenotype, major neuropathologic lesions, and pathogenesis
26. Neurophysiologic follow-up of long-term dietary treatment in adult-onset adrenoleucodystrophy
27. Tumor necrosis factor mediated myelin and oligodendrocyte damage in vitro
28. DNA diagnosis of X-linked adrenoleukodystrophy
29. An adult case of adrenoleukodystrophy with features of olivo-ponto-cerebellar atrophy
30. Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleucodystrophy during treatment with "Lorenzo's oil"